Decoration of Cisplatin on 2D Metal–Organic Frameworks for Enhanced Anticancer Effects through Highly Increased Reactive Oxygen Species Generation
Source abstract
Abstract
Herein, a biocompatible 2D metal-organic frameworks (Cu-TCPP(Fe)) based on TCPP(M) (TCPP = tetrakis (4-carboxyphenyl) porphyrin, M = Fe) and copper ion were synthesized as a novel drug carrier. Sequentially, the cisplatin was loaded on the merge of carboxyl-rich Cu-TCPP(Fe) through forming favorable carboxyl-drug interactions. The prepared Pt/Cu-TCPP(Fe) showed highly enhanced cytotoxicity than that of free cisplatin in human pulmonary carcinoma A549 cells, whereas inverse inhibitory effects were observed in human normal BEAS-2B cells. Further, the mechanism of action about the desirable results was also elaborated. Our study highlighted the potential synergies between the nanocarrier and the anticancer drugs.
Source: openalex_inverted_index · Quality: baseline
Research context
OpenAlex topics: Metal-Organic Frameworks: Synthesis and Applications · Nanoplatforms for cancer theranostics · Dendrimers and Hyperbranched Polymers
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
Affiliations
School of Chemistry and Chemical Engineering, Southeast University, Nanjing 210089, PR China
Department of Respiratory Medicine, The Affiliated Zhongda Hospital of Southeast University, Nanjing 210009, PR China
Funding
Ministry of Science and Technology of the People's Republic of China · National Natural Science Foundation of China · Priority Academic Program Development of Jiangsu Higher Education Institutions
References (24)
Show source-provided references
1. 10.1038/nmat411310.1038/nmat4113 ↗
2. 10.1016/j.memsci.2017.06.01110.1016/j.memsci.2017.06.011 ↗
3. 10.1002/adma.20170010210.1002/adma.201700102 ↗
4. 10.1016/j.bios.2016.06.03610.1016/j.bios.2016.06.036 ↗
5. 10.1007/s10008-013-2027-110.1007/s10008-013-2027-1 ↗
6. 10.1142/S108842461250150710.1142/S1088424612501507 ↗
7. 10.1021/acs.chemrev.6b0055810.1021/acs.chemrev.6b00558 ↗
8. 10.1021/acs.chemrev.7b0072710.1021/acs.chemrev.7b00727 ↗
9. 10.1002/adma.20160010810.1002/adma.201600108 ↗
10. 10.1080/09205063.2017.142134810.1080/09205063.2017.1421348 ↗
11. 10.1002/chem.20170005910.1002/chem.201700059 ↗
12. 10.1016/j.biomaterials.2012.05.04910.1016/j.biomaterials.2012.05.049 ↗
13. 10.1002/admi.20140018210.1002/admi.201400182 ↗
14. 10.1088/1361-6528/aabf5910.1088/1361-6528/aabf59 ↗
15. 10.1021/acsami.6b0388110.1021/acsami.6b03881 ↗
16. 10.1517/17425247.2014.95305110.1517/17425247.2014.953051 ↗
17. 10.1021/acs.nanolett.6b0426910.1021/acs.nanolett.6b04269 ↗
18. 10.1523/JNEUROSCI.6054-09.201010.1523/JNEUROSCI.6054-09.2010 ↗
19. 10.1002/anie.20151003110.1002/anie.201510031 ↗
20. 10.1016/j.jhazmat.2014.04.05410.1016/j.jhazmat.2014.04.054 ↗
21. 10.3109/1071576100366755410.3109/10715761003667554 ↗
22. 10.1089/ars.2012.501410.1089/ars.2012.5014 ↗
23. 10.1021/acsabm.8b0005610.1021/acsabm.8b00056 ↗
24. 10.1021/acs.chemmater.7b0475110.1021/acs.chemmater.7b04751 ↗